Citadel Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-111,500
Closed -$23.7M 15584
2023
Q3
$23.7M Sell
111,500
-228,000
-67% -$45.5M 0.01% 1690
2023
Q2
$65.3M Buy
339,500
+299,300
+745% +$59.5M 0.01% 849
2023
Q1
$8.14M Sell
40,200
-36,500
-48% -$5.85M ﹤0.01% 3080
2022
Q4
$9.86M Buy
76,700
+49,900
+186% +$6.44M ﹤0.01% 2867
2022
Q3
$3.67M Sell
26,800
-157,600
-85% -$25.7M ﹤0.01% 4412
2022
Q2
$32.6M Buy
184,400
+152,300
+474% +$21.9M 0.01% 1407
2022
Q1
$4.62M Sell
32,100
-32,400
-50% -$4.38M ﹤0.01% 4326
2021
Q4
$9.97M Sell
64,500
-53,300
-45% -$8.92M ﹤0.01% 3078
2021
Q3
$20M Buy
117,800
+70,700
+150% +$11M ﹤0.01% 1983
2021
Q2
$7.44M Sell
47,100
-27,200
-37% -$4.04M ﹤0.01% 3627
2021
Q1
$10.3M Sell
74,300
-10,100
-12% -$1.63M ﹤0.01% 2917
2020
Q4
$14.8M Sell
84,400
-17,200
-17% -$3.21M ﹤0.01% 2144
2020
Q3
$19.9M Buy
101,600
+10,100
+11% +$1.69M 0.01% 1577
2020
Q2
$15.5M Buy
91,500
+46,700
+104% +$6.97M 0.01% 1738
2020
Q1
$5.17M Buy
44,800
+4,100
+10% +$454K ﹤0.01% 2657
2019
Q4
$4.65M Sell
40,700
-48,700
-54% -$5.16M ﹤0.01% 3165
2019
Q3
$7.63M Buy
89,400
+47,600
+114% +$3.49M ﹤0.01% 2553
2019
Q2
$2.89M Sell
41,800
-95,000
-69% -$6.65M ﹤0.01% 3916
2019
Q1
$10M Buy
136,800
+107,200
+362% +$7.63M 0.01% 2074
2018
Q4
$1.68M Sell
29,600
-800
-3% -$50.2K ﹤0.01% 4425
2018
Q3
$2.34M Buy
30,400
+20,400
+204% +$1.5M ﹤0.01% 4139
2018
Q2
$664K Sell
10,000
-8,000
-44% -$458K ﹤0.01% 5908
2018
Q1
$942K Sell
18,000
-7,600
-30% -$414K ﹤0.01% 4908
2017
Q4
$1.37M Buy
25,600
+1,300
+5% +$75.9K ﹤0.01% 4169
2017
Q3
$1.32M Sell
24,300
-8,400
-26% -$430K ﹤0.01% 3932
2017
Q2
$1.69M Buy
32,700
+18,900
+137% +$1.2M ﹤0.01% 3389
2017
Q1
$867K Sell
13,800
-19,800
-59% -$1.24M ﹤0.01% 4218
2016
Q4
$1.77M Buy
33,600
+16,500
+96% +$992K ﹤0.01% 3106
2016
Q3
$924K Sell
17,100
-4,000
-19% -$190K ﹤0.01% 3938
2016
Q2
$853K Sell
21,100
-32,700
-61% -$1.24M ﹤0.01% 3765
2016
Q1
$1.89M Sell
53,800
-29,900
-36% -$1M ﹤0.01% 2701
2015
Q4
$3.76M Buy
83,700
+22,600
+37% +$941K ﹤0.01% 2084
2015
Q3
$2.36M Sell
61,100
-4,100
-6% -$185K ﹤0.01% 2741
2015
Q2
$3.16M Buy
65,200
+22,500
+53% +$928K ﹤0.01% 2529
2015
Q1
$1.51M Sell
42,700
-14,300
-25% -$488K ﹤0.01% 3429
2014
Q4
$1.83M Buy
57,000
+200
+0.4% +$6.97K ﹤0.01% 3017
2014
Q3
$2.11M Buy
56,800
+11,700
+26% +$460K ﹤0.01% 2797
2014
Q2
$1.73M Buy
45,100
+32,000
+244% +$1.21M ﹤0.01% 2875
2014
Q1
$597K Sell
13,100
-11,700
-47% -$560K ﹤0.01% 4093
2013
Q4
$989K Sell
24,800
-2,500
-9% -$102K ﹤0.01% 3235
2013
Q3
$1.2M Buy
27,300
+18,500
+210% +$770K ﹤0.01% 2909
2013
Q2
$277K Buy
+8,800
New +$307K ﹤0.01% 4370

Other funds holding SGEN

Citadel Advisors's SGEN Position: Q4 2023 in Review

Citadel Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 2,428,418 shares — an estimated $515M sold.

Citadel Advisors first reported a position in SGEN in Q2 2013 and held it in 39 quarters. The position peaked at $515M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Citadel Advisors reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 2,428,418 Seagen Inc. Common Stock shares in Q4 2023, an estimated $515M.
  • Citadel Advisors first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 39 quarters.
  • Citadel Advisors's Seagen Inc. Common Stock position peaked at $515M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.